US Patent 7705146 Hepatitis C inhibitor peptide analogs
Patent 7705146 was granted and assigned to Boehringer Ingelheim on April, 2010 by the United States Patent and Trademark Office.
All edits
Edits on 30 Oct, 2023
Golden AI
Edits made to:
Article (+420 characters)
Article
Patent abstract
The invention relates to compounds of formula (I) wherein R′, R2, R3, R4, R5, R6, Y, n and m are as defined herein. The compounds are useful for the treatment and prevention of hepatitis C viral infections in mammals by inhibiting HCV NS3 protease. The invention further relates to azalactone compounds of the formula (III) which can be reacted with an amide anion to produce the compounds of formula (I).
Edits on 18 Sep, 2023
Golden AI
Edits made to:
Infobox (+9 properties)
Infobox
Patent Inventor Names
Elise Ghiro0
Jean Rancourt0
Marc-Andre Poupart0
Montse Llinas-Brunet0
Murray D. Bailey0
Nathalie Goudreau0
Pasquale Forgione0
Punit Bhardwaj0
Teddy Halmos0
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07705146 Hepatitis C inhibitor peptide analogs US Patent 7705146 Hepatitis C inhibitor peptide analogs
Infobox
Patent Number
07705146
Patent Number
7705146
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 4 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07705146 Hepatitis C inhibitor peptide analogs
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07705146
Date of patent
April 27, 2010
Patent application number
10595108
Date Filed
June 22, 2005
Patent primary examiner
Find more entities like US Patent 7705146 Hepatitis C inhibitor peptide analogs
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.